NO953967L - Indolderivater som 5-HT1A og/eller 5-HT2 ligander - Google Patents
Indolderivater som 5-HT1A og/eller 5-HT2 liganderInfo
- Publication number
- NO953967L NO953967L NO953967A NO953967A NO953967L NO 953967 L NO953967 L NO 953967L NO 953967 A NO953967 A NO 953967A NO 953967 A NO953967 A NO 953967A NO 953967 L NO953967 L NO 953967L
- Authority
- NO
- Norway
- Prior art keywords
- indole derivatives
- ht1a
- ligands
- derivatives
- processes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI930699A IT1271352B (it) | 1993-04-08 | 1993-04-08 | Derivati dell'indolo utili nel trattamento dei disturbi del sistema nervoso centrale |
| PCT/EP1994/001016 WO1994024125A1 (en) | 1993-04-08 | 1994-03-31 | Indole derivatives as 5-ht1a and/or 5-ht2 ligands |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO953967D0 NO953967D0 (no) | 1995-10-05 |
| NO953967L true NO953967L (no) | 1995-12-05 |
Family
ID=11365694
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO953967A NO953967L (no) | 1993-04-08 | 1995-10-05 | Indolderivater som 5-HT1A og/eller 5-HT2 ligander |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US5834493A (sv) |
| EP (1) | EP0694033A1 (sv) |
| JP (1) | JPH08508738A (sv) |
| CN (1) | CN1124960A (sv) |
| AU (1) | AU684276B2 (sv) |
| BG (1) | BG100040A (sv) |
| BR (1) | BR9406206A (sv) |
| CA (1) | CA2160020A1 (sv) |
| CZ (1) | CZ283398B6 (sv) |
| FI (1) | FI954734A0 (sv) |
| HU (1) | HUT74090A (sv) |
| IL (1) | IL109234A (sv) |
| IT (1) | IT1271352B (sv) |
| NO (1) | NO953967L (sv) |
| NZ (1) | NZ265055A (sv) |
| PL (1) | PL310995A1 (sv) |
| SG (1) | SG50507A1 (sv) |
| SK (1) | SK119795A3 (sv) |
| WO (1) | WO1994024125A1 (sv) |
| ZA (1) | ZA942383B (sv) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9420521D0 (en) * | 1994-10-12 | 1994-11-30 | Smithkline Beecham Plc | Novel compounds |
| SK285221B6 (sk) * | 1997-05-09 | 2006-09-07 | H. Lundbeck A/S | Spôsob výroby sertindolu a medziproduktov |
| US6673827B1 (en) | 1999-06-29 | 2004-01-06 | The Uab Research Foundation | Methods of treating fungal infections with inhibitors of NAD synthetase enzyme |
| DE69918799D1 (de) | 1998-01-14 | 2004-08-26 | Uab Res Foundation Birmingham | Verfahren zur herstellung und screening von inhibitoren des bakteriellen nad synthetase enzyms, verbindungen daraus und methoden zur behandlung bakterieller und mikrobieller infektionen mit diesen inhibitoren |
| US6861448B2 (en) * | 1998-01-14 | 2005-03-01 | Virtual Drug Development, Inc. | NAD synthetase inhibitors and uses thereof |
| US6133287A (en) * | 1998-03-24 | 2000-10-17 | Allelix Biopharmaceuticals Inc. | Piperidine-indole compounds having 5-HT6 affinity |
| ES2182509T3 (es) * | 1998-04-08 | 2003-03-01 | Wyeth Corp | Derivados de n-ariloxietilamina para el tratamiento de la depresion. |
| CN1307576A (zh) * | 1998-04-29 | 2001-08-08 | 美国家用产品公司 | 5－羟色胺能药物 |
| FR2799463B1 (fr) * | 1999-10-12 | 2004-04-16 | Adir | Nouveaux composes cyano-indoles inhibiteurs de recapture de serotonine, leur procede de preparation et ces compositions pharmaceutiques qui les contiennent |
| DE19951360A1 (de) * | 1999-10-26 | 2001-05-03 | Aventis Pharma Gmbh | Substituierte Indole |
| US6503894B1 (en) | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
| CN1492863A (zh) * | 2000-12-22 | 2004-04-28 | 作为5-羟色胺-6配基的杂环基烷基-吲哚或氮杂吲哚化合物 | |
| US7135479B2 (en) | 2002-09-12 | 2006-11-14 | Wyeth | Antidepressant azaheterocyclylmethyl derivatives of heterocycle-fused benzodioxans |
| JP5894574B2 (ja) * | 2010-04-22 | 2016-03-30 | イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−Ｃｅｌｌｕｌａｒ Ｔｈｅｒａｐｉｅｓ， Ｉｎｃ． | 有機化合物 |
| ES2727815T3 (es) | 2012-04-14 | 2019-10-18 | Intra Cellular Therapies Inc | Tratamiento del TEPT y de trastornos del control de impulsos |
| EP2968320B1 (en) | 2013-03-15 | 2020-11-11 | Intra-Cellular Therapies, Inc. | Organic compounds |
| KR102495941B1 (ko) | 2013-12-03 | 2023-02-06 | 인트라-셀룰라 써래피스, 인코퍼레이티드. | 신규한 방법 |
| MX2016013046A (es) | 2014-04-04 | 2017-02-15 | Intra-Cellular Therapies Inc | Compuestos organicos. |
| BR112016023162B1 (pt) | 2014-04-04 | 2022-11-29 | Intra-Cellular Therapies, Inc | Compostos orgânicos gama-carbolinas, composições farmacêuticas compreendendo os ditos compostos e uso dos mesmos no tratamento ou na profilaxia de transtornos de sistema nervoso central |
| WO2017023894A1 (en) * | 2015-08-03 | 2017-02-09 | Raze Therapeutics, Inc. | Mthfd2 inhibitors and uses thereof |
| BR112018015283B1 (pt) | 2016-01-26 | 2023-09-26 | Intra-Cellular Therapies, Inc | Compostos orgânicos, composição farmacêutica compreendendo os ditos compostos e uso dos mesmos para o tratamento ou profilaxia de um distúrbio do sistema nervoso central |
| EP3888656A1 (en) | 2016-03-25 | 2021-10-06 | Intra-Cellular Therapies, Inc. | Deuterated heterocyclic gamma-carboline compounds and their use in the treatment or prophylaxis of a central nervous system disorder |
| WO2017172795A1 (en) | 2016-03-28 | 2017-10-05 | Intra-Cellular Therapies, Inc. | Novel compositions and methods |
| US11331316B2 (en) | 2016-10-12 | 2022-05-17 | Intra-Cellular Therapies, Inc. | Amorphous solid dispersions |
| US10961245B2 (en) | 2016-12-29 | 2021-03-30 | Intra-Cellular Therapies, Inc. | Substituted heterocycle fused gamma-carbolines for treatment of central nervous system disorders |
| WO2018126143A1 (en) | 2016-12-29 | 2018-07-05 | Intra-Cellular Therapies, Inc. | Organic compounds |
| CA3054841A1 (en) | 2017-03-24 | 2018-09-27 | Intra-Cellular Therapies, Inc. | Novel compositions and methods |
| WO2019023063A1 (en) | 2017-07-26 | 2019-01-31 | Intra-Cellular Therapies, Inc. | ORGANIC COMPOUNDS |
| MX2020000968A (es) | 2017-07-26 | 2020-09-28 | Intra Cellular Therapies Inc | Compuestos organicos. |
| EP3843738A4 (en) | 2018-08-31 | 2022-06-01 | Intra-Cellular Therapies, Inc. | NEW METHODS |
| WO2020047408A1 (en) | 2018-08-31 | 2020-03-05 | Intra-Cellular Therapies, Inc. | Novel methods |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0429341A3 (en) * | 1989-11-20 | 1991-11-13 | Rhone-Poulenc Sante | Heterocyclic derivatives, their preparation and pharmaceuticals containing them |
| HUT64326A (en) * | 1990-10-15 | 1993-12-28 | Pfizer | Process for production indole derivatives and pharmaceutical preparations containing these compounds |
| JP3140155B2 (ja) * | 1992-03-09 | 2001-03-05 | 杏林製薬株式会社 | Ｎ，ｎ’−ジ置換アミド誘導体 |
| CA2092112A1 (en) * | 1992-03-23 | 1993-09-24 | Nobuyoshi Iwata | Indole and indazole derivatives, for the treatment and prophylaxis of cerebral disorders, their preparation and their use |
-
1993
- 1993-04-08 IT ITMI930699A patent/IT1271352B/it active IP Right Grant
-
1994
- 1994-03-31 AU AU65382/94A patent/AU684276B2/en not_active Ceased
- 1994-03-31 PL PL94310995A patent/PL310995A1/xx unknown
- 1994-03-31 CA CA002160020A patent/CA2160020A1/en not_active Abandoned
- 1994-03-31 EP EP94913101A patent/EP0694033A1/en not_active Withdrawn
- 1994-03-31 JP JP6522684A patent/JPH08508738A/ja active Pending
- 1994-03-31 WO PCT/EP1994/001016 patent/WO1994024125A1/en not_active Application Discontinuation
- 1994-03-31 HU HU9502913A patent/HUT74090A/hu unknown
- 1994-03-31 CN CN94192345A patent/CN1124960A/zh active Pending
- 1994-03-31 SG SG1996002949A patent/SG50507A1/en unknown
- 1994-03-31 SK SK1197-95A patent/SK119795A3/sk unknown
- 1994-03-31 US US08/530,354 patent/US5834493A/en not_active Expired - Fee Related
- 1994-03-31 NZ NZ265055A patent/NZ265055A/en unknown
- 1994-03-31 BR BR9406206A patent/BR9406206A/pt not_active Application Discontinuation
- 1994-03-31 CZ CZ952602A patent/CZ283398B6/cs unknown
- 1994-04-06 IL IL109234A patent/IL109234A/en not_active IP Right Cessation
- 1994-04-07 ZA ZA942383A patent/ZA942383B/xx unknown
-
1995
- 1995-10-02 BG BG100040A patent/BG100040A/bg unknown
- 1995-10-05 FI FI954734A patent/FI954734A0/sv unknown
- 1995-10-05 NO NO953967A patent/NO953967L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HU9502913D0 (en) | 1995-11-28 |
| CZ283398B6 (cs) | 1998-04-15 |
| PL310995A1 (en) | 1996-01-22 |
| JPH08508738A (ja) | 1996-09-17 |
| CA2160020A1 (en) | 1994-10-27 |
| AU684276B2 (en) | 1997-12-11 |
| HUT74090A (en) | 1996-11-28 |
| FI954734A (sv) | 1995-10-05 |
| ITMI930699A0 (it) | 1993-04-08 |
| CN1124960A (zh) | 1996-06-19 |
| IL109234A (en) | 1998-04-05 |
| WO1994024125A1 (en) | 1994-10-27 |
| US5834493A (en) | 1998-11-10 |
| NO953967D0 (no) | 1995-10-05 |
| ZA942383B (en) | 1995-10-09 |
| SK119795A3 (en) | 1996-04-03 |
| BG100040A (bg) | 1996-03-29 |
| NZ265055A (en) | 1996-09-25 |
| IT1271352B (it) | 1997-05-27 |
| AU6538294A (en) | 1994-11-08 |
| SG50507A1 (en) | 1998-07-20 |
| ITMI930699A1 (it) | 1994-10-08 |
| IL109234A0 (en) | 1994-07-31 |
| EP0694033A1 (en) | 1996-01-31 |
| CZ260295A3 (en) | 1996-01-17 |
| BR9406206A (pt) | 1996-02-06 |
| FI954734A0 (sv) | 1995-10-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO953967L (no) | Indolderivater som 5-HT1A og/eller 5-HT2 ligander | |
| NO961687D0 (no) | Nye (R)-5-karbamoyl-8-fluor-3-N,N-disubstituerte-amino-3,4-dihydro-2H-1-benzopyraner | |
| CA2148928A1 (en) | Pharmacologically active pyridine derivatives and processes for the preparation thereof | |
| YU48765B (en) | Amides isoxasole - 4 - carbon acid and amides of hidroxy-alkiliden ciano vinegar acid and the procedure for obtaining pharmaceutic preparations containing those compounds | |
| IL104006A (en) | Azaheterocyclylmethyl-chromans their preparation and pharmaceutical compositions containing them | |
| NO972910L (no) | Tetracykliske spiroforbindelser, fremgangsmåte for fremstilling og anvendelse derav som 5HT1D reseptor-antagonister | |
| NO883229D0 (no) | Nye benzimidazolderivater, fremgangsmaate for deres fremstilling og farmasoeytisk preparat inneholdende slike derivater. | |
| ATE206708T1 (de) | Benzimidazolonderivate mit zentraler dopaminerger aktivität | |
| CA2094703A1 (en) | Substituted piperazines as central nervous system agents | |
| MX9403088A (es) | Composiciones farmaceuticas que contienen deriva- dos de indol y metodos de uso. | |
| DK0825197T3 (da) | Nye 6-hydroxy- og 6-oxo-androstanderivater, der er aktive i forhold til det cardiovaskulære system, og farmaceutiske præpar | |
| ATE242220T1 (de) | Benzimidazolderivate mit dopaminerger wirkung | |
| ATE229953T1 (de) | Naphtho-imidazo(1,2-a)pyridin derivate, deren herstellung und deren verwendung in der behandlung von störungen des zentralnervensystems | |
| DK162440C (da) | Pyrazindiazohydroxidforbindelser | |
| GEP19980890B (en) | Derivatives of N1-(1,2-Cis-halogeno¬-cyclopropyl) Substituted Pyridonecarbonic Acid | |
| UA27738C2 (uk) | 2,3,4,5,6,7-гексагідро-1-[4-[1-[4-(2метоксифеніл)піперазиніл]]-2-фенілбутирил]-1н-азепін або його фармацевтично прийнятна кислотно-адитивна сіль, що мають властивість пов'язувати рецептор 5нт1а, спосіб (варіанти) їх одержання, фармацевтична композиція | |
| NO970498L (no) | Benzimidazolderivater med dopaminergisk aktivitet |